Moreover, recent studies had demonstrated that TWEAK and Fn14 were over-expressed in gliomas with a high level of NF-κB activation, suggesting that the TWEAK-NF-κB axis might serve as a potential target of neuroregulatory mechanisms in a context-specific manner [20]. The gene discussed is TNFSF12; the disease is central nervous system cancer.